ArticlePreventive medicine reports2026
Lung cancer screening outcomes among people with HIV at an academic medical center in South Carolina: insights from electronic health records and provider survey data 2023.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To examine lung cancer screening (LCS) outcomes in people living with HIV (PLWH). Further, we aimed to understand perspectives of providers regarding LCS in PLWH to contextualize current screening outcomes and referrals. Methods: Phase 1 involved electronic health record review to identify PLWH who had undergone a shared decision-making visit and LCS from 2015 to 2023 at Medical University of South Carolina (MUSC). Inclusion criteria were consistent with LCS eligibility criteria plus HIV diagnosis. Shared decision making visits were completed by 61 PLWH. Phase 2 included a survey of infectious disease providers' ( Results: In Phase 1, 97% ( Conclusions: Among PLWH who completed a LCS, a clinically meaningful proportion had positive findings, including early-stage cancers. Findings from this study could be used to improve implementation of LCS programs in PLWH and programs to educate providers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.